BSE filing, NSE: AMANTA. Summary written from the filing by ALFA Finder's alert engine.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹163.19
- Market cap
- ₹633.7 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 43.2×Sector 46.5×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Board Meeting Date
Amanta Healthcare intimated a Board Meeting scheduled for 3 Nov 2026 to approve Q1 & H1 FY27 unaudited results. Trading window reopens on 6 Nov 2026.
Amanta Healthcare Promoter Selling (Off-Market)
Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare, disposed of 17,32,763 equity shares via an off-market gift. His stake decreased from 4.72% to 0.26%.
Amanta Healthcare Promoter Selling (Off-Market): ₹2.86 Cr
Promoter Pravinchandra Mehta sold 1,50,400 shares of Amanta Healthcare to fellow promoter Kirit Desai in an off-market inter-se transfer valued at ₹2.86 Crore.
- Value
- ₹2.86 Cr
Amanta Healthcare Promoter Buying (Off-Market): ₹2.86 Cr
Amanta Healthcare reported an inter-se off-market transfer of 1,50,400 equity shares between promoter group members. Kirit Ambalal Desai acquired the stake valued at ₹2.86 Crore from Pravinchandra Dhanjibhai Mehta.
- Value
- ₹2.86 Cr
- Promoter stake change
- +0.39%
Amanta Healthcare Promoter Buying (Off-Market): ₹5.72 Cr
Pravinchandra Dhanjibhai Mehta and Kirit Ambalal Desai, members of the promoter group, acquired 1,50,400 shares each via off-market inter-se transfers. Both transactions were valued at Rs. 2.86 Crore each.
- Value
- ₹5.72 Cr
- Promoter stake change
- +0.39%
Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.